Approval · Notice of Compliance 20186 · 2017
ZOLADEX: Notice of Compliance 20186
Issued December 21, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20186
- Date
- December 21, 2017
- Company
- Tersera Therapeutics LlcDeerfield, Illinois, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Transfer of Drug Identification Number and updates to labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZOLADEX | 02049325 | Marketed |
| ZOLADEX LA | 02225905 | Marketed |
Medicinal ingredients
- GOSERELIN ACETATE 3.6 MG per IMP
- GOSERELIN ACETATE 10.8 MG per IMP